Contrast agent developer E-Z-EM of Westbury, NY, will gain access to new markets in Europe thanks to an agreement with Nycomed Amersham.
Under the terms of the three-year deal, Nycomed Amersham of Buckinghamshire, U.K. will distribute E-Z-EM's gastrointestinal contrast products in Central Eastern Europe. The deal gives Nycomed exclusive distribution rights in the Czech Republic, Hungary, Romania, Bulgaria, Slovakia, and Albania, and semi-exclusive rights in Poland.
By AuntMinnie.com staff writersDecember 18, 2000
Related Reading
E-Z-EM reports flat Q1, October 13, 2000
E-Z-EM turns in record net sales in fiscal 2000, August 7, 2000
E-Z-EM names Lombardo as CEO, April 3, 2000
Copyright © 2000 AuntMinnie.com
















![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)

